Does PALIVIZUMAB Cause Injection site urticaria? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Injection site urticaria have been filed in association with PALIVIZUMAB (Synagis). This represents 0.0% of all adverse event reports for PALIVIZUMAB.
5
Reports of Injection site urticaria with PALIVIZUMAB
0.0%
of all PALIVIZUMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site urticaria From PALIVIZUMAB?
Of the 5 reports.
Is Injection site urticaria Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALIVIZUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does PALIVIZUMAB Cause?
Respiratory syncytial virus infection (1,692)
Pyrexia (1,055)
Death (856)
Bronchiolitis (724)
Cough (665)
Pneumonia (657)
Dyspnoea (466)
Nasopharyngitis (462)
Vomiting (445)
Influenza (398)
What Other Drugs Cause Injection site urticaria?
DUPILUMAB (3,104)
ETANERCEPT (2,780)
ADALIMUMAB (2,188)
GLATIRAMER (1,091)
TIRZEPATIDE (842)
IXEKIZUMAB (652)
EVOLOCUMAB (486)
GALCANEZUMAB-GNLM (478)
DULAGLUTIDE (450)
HUMIRA (346)
Which PALIVIZUMAB Alternatives Have Lower Injection site urticaria Risk?
PALIVIZUMAB vs PALONOSETRON
PALIVIZUMAB vs PAMIDRONATE
PALIVIZUMAB vs PAMIDRONIC ACID
PALIVIZUMAB vs PANCRELIPASE
PALIVIZUMAB vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE